助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   oral etoposide 的翻译结果: 查询用时:0.165秒
图标索引 在分类学科中查询
所有学科
肿瘤学
更多类别查询

图标索引 历史查询
 

oral etoposide
相关语句
  口服依托泊甙
     Clinical Observations of Advanced Non Small Cell Lung Cancer Patients Treated with Continuous Infusion of Cisplatin and Oral Etoposide
     持续静滴顺铂与口服依托泊甙治疗晚期非小细胞肺癌的临床观察
短句来源
     Chronic daily adminisitration of oral etoposide capsule in lung cancer and malignant lymphoma
     长期口服依托泊甙胶囊治疗肺癌和恶性淋巴瘤
短句来源
     Objective To study the efficacy of continuous infusion of cisplatin and oral etoposide in the treatment of non small cell lung cancer (NSCLC).
     目的 探讨持续静滴顺铂与口服依托泊甙 (VP - 16 )治疗非小细胞肺癌 (NSCLC)。
短句来源
  “oral etoposide”译为未确定词的双语例句
     Analysis of the Short Term Effect of Low Dose Oral Etoposide (Vp-16)For 18 Cases of Advanced Gastric Carcinoma.
     低剂量口服Vp-16治疗晚期胃癌18例近期疗效分析
短句来源
     METHODS: Twenty two patients with NSCLC were treated with oral etoposide (46± s 3) mg·m -2 ·d -1 (41-52 mg·m -2 ·d -1 ), qm, ac×21d, Every 28-35 d was a peried.
     方法 :对 2 2例晚期非小细胞肺癌病人采用依托泊苷软胶囊口服 ,剂量按 5 0mg·m- 2 ·d- 1计算 ,实际剂量 (46±s3)mg·m- 2 ·d- 1,晨起空腹一次顿服 ,连服 2 1d ,每 2 8~ 35d为一个周期。
短句来源
     Oral Etoposide (Lastet Cap. ) Treated 27 Cases of Advanced Malignant Tumours by Combined Chemotherapy
     拉司太特联合化疗治疗晚期恶性肿瘤27例
短句来源
     18 cases of Advance Gastric Carcinoma were treated with combined modality predominated by low dose oral etoposide(Vp16). The results showed that respons rate was 44.4%(CR1,PR7).
     用低剂量口服Vp-16的ELF(CF/5Fu、Vp-16)方案治疗的均经病理证实的晚期胃癌18例,结果CR1例,PR7例,总有效率(CR+PR)44.4%,至现在存活时间最长的为34个月,最短的为2个月,中位生存期8.6个月。
短句来源
     METHODS:Thirty-two patients with NSCLC were treated with oral etoposide once daily for 21 days. Etoposide dose per body-surface area ranged from 41 to 52mg/m2.d-1(mean ±46).
     方法:足叶乙甙按50mn·m-2·d-1剂量给药,实际剂量41-52mm/m2·d-1(mean± 46),晨起空腹一次顿服,连服 21d。
短句来源
更多       
  相似匹配句对
     Efficacy of Oral Etoposide in the Treatment of Lung Cancer
     低剂量长疗程口服足叶乙甙对肺癌的治疗作用
短句来源
     CLINICAL TRIAL OF ORAL ETOPOSIDE IN THE TREATMENT OF MALIGNANCIES
     鬼臼乙叉甙软胶囊治疗恶性肿瘤的临床验证报告
短句来源
     On Oral Confession
     论口供
短句来源
     Oral English
     英语口语
短句来源
     The toxicity of etoposide to the retina of rabbit
     足叶乙苷玻璃体内注射对兔视网膜损伤的研究
短句来源
查询“oral etoposide”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  oral etoposide
Combined IA cisplatin and oral etoposide was well-tolerated, but produced an objective response in only a minority of patients.
      
Oral etoposide 50 mg/m2/day was given days 1-21, with a 7 day rest interval between courses.
      
Our objective was to test the efficacy of combining intra-arterially (IA) infused cisplatin and oral etoposide.
      
Intra-arterial Cisplatin Plus Oral Etoposide for the Treatment of Recurrent Malignant Glioma: A Phase II Study
      
Because relatively good results have been achieved with combinations of platin compounds and etoposide, we investigated a dose-intensified cisplatin regimen with oral etoposide.
      
更多          


Seventeen patients with lung cancer and malignant lymphoma were treated with combination chemotherapy including oral etoposide (Eto). The efficacy of oral Eto was compared with that of iv in 10 patients in same chemotherapy regimen. The overall response rates were 88%(oral) and 60%(iv), respectively. In lung cancer patients, the response rate(89%) is oral treatment was higher than that(43%) in iv, P< 0.05. Toxic effects induced by Eto were not different between the two regimens. Our results...

Seventeen patients with lung cancer and malignant lymphoma were treated with combination chemotherapy including oral etoposide (Eto). The efficacy of oral Eto was compared with that of iv in 10 patients in same chemotherapy regimen. The overall response rates were 88%(oral) and 60%(iv), respectively. In lung cancer patients, the response rate(89%) is oral treatment was higher than that(43%) in iv, P< 0.05. Toxic effects induced by Eto were not different between the two regimens. Our results showed that the curative effect in oral treatment was close to that in iv. As the patient number is not large enough, the results are preliminary and necessary to study further.

用依托泊甙(Eto)胶囊口服用药联合化疗方案治疗肺癌和恶性淋巴瘤17人,并以10例静脉滴注Eto作对照。结果:口服Eto胶囊组总有效率为88%,对照组为60%。肺癌口服Eto胶囊治疗组有效率(89%)明显高于对照组(43%),P<0.05。2组毒副作用相似。提示:口服Eto胶囊联合化疗对肺癌和恶性淋巴瘤的疗效不低于静脉用药组,值得进一步研究。

New progress in recent clinical studies of Etoposide is re- viewed.The results of phase I and phase Ⅱ clinical trils showed that low-dose chronic oral Etoposide were effective to the elder,poor performance status and advanced previously treated,relapsed,refractory patients with solid tumors such as small cell lung cancer,non-small cell lung cancer,malignant lymphoma,genitouri- nary tumor,gynecologic tumor and breast cancer,ets. Etoposide was used in a dose of 50mg/(m ̄2·d)for a period of 14...

New progress in recent clinical studies of Etoposide is re- viewed.The results of phase I and phase Ⅱ clinical trils showed that low-dose chronic oral Etoposide were effective to the elder,poor performance status and advanced previously treated,relapsed,refractory patients with solid tumors such as small cell lung cancer,non-small cell lung cancer,malignant lymphoma,genitouri- nary tumor,gynecologic tumor and breast cancer,ets. Etoposide was used in a dose of 50mg/(m ̄2·d)for a period of 14 to 21 days,with the main adverse reactions of slight and moderate myelosuppression, heavy alopecia, and slight gastrointestinal sympom. It’s a safe and effective drug can be used in ambulatory.

综述了近年来鬼臼乙叉甙临床研究的新进展。I、Ⅱ期临床研究的结果表明,鬼臼乙叉甙低剂量长期日服对高龄、一般状态差、既往接受过治疗的晚期复发及耐药的恶性实体瘤,如小细胞肺癌、非小细胞肺癌、恶性淋巴瘤、泌尿生殖系统肿瘤、妇科肿瘤、乳癌等,具有良好的疗效。鬼臼乙叉甙50mg/(m ̄2·d),持续口服14~21d时,主要的毒副反应是轻中度的骨髓抑制、重度脱发和轻度的胃肠道反应。此疗法安全可靠,疗效确切,门诊即可接受治疗。

This study reports the efficacy of prolonged administration of oral etoposide in the treatment of 86 cases with solid tumor,malignant lymphoma and other cancer.The oral etoposide used was the Lastet capsule (Las-c).An overall response rate(RR)of 62.8% was achieved with CR rate being 23.3% and PR rate 39.5%. Different combination chemotherapy regimens led to different response rates but no significant difference was found. The Las-C containing regimens used in this study have not caused any serious...

This study reports the efficacy of prolonged administration of oral etoposide in the treatment of 86 cases with solid tumor,malignant lymphoma and other cancer.The oral etoposide used was the Lastet capsule (Las-c).An overall response rate(RR)of 62.8% was achieved with CR rate being 23.3% and PR rate 39.5%. Different combination chemotherapy regimens led to different response rates but no significant difference was found. The Las-C containing regimens used in this study have not caused any serious side effects.

PHASEIICLINICALTRIALOFLASTETCAPSULEINCOMBINATIONCHEMOTHERAPYOFMALIGNANTTUMORSINCHINAZhangtianze;张天泽;YinJiliang;印季良;HeYoujian;...

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关oral etoposide的内容
在知识搜索中查有关oral etoposide的内容
在数字搜索中查有关oral etoposide的内容
在概念知识元中查有关oral etoposide的内容
在学术趋势中查有关oral etoposide的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社